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Gene expression profiling of tumors is a successful tool for the discovery of new cancer bio-
markers and potential targets for the development of new therapeutic strategies. Reliable
profiling is preferably performed on fresh frozen (FF) tissues in which the quality of nucleic
acids is better preserved than in formalin-fixed paraffin-embedded (FFPE) material. How-
ever, since snap-freezing of biopsy materials is often not part of daily routine in pathology
laboratories, one may have to rely on archival FFPE material. Procedures to retrieve the
RNAs from FFPE materials have been developed and therefore, datasets obtained from
FFPE and FF materials need to be made compatible to ensure reliable comparisons are
possible.
Aim
To develop an efficient method to compare gene expression profiles obtained from FFPE
and FF samples using the same platform.
Methods
Twenty-six FFPE-FF sample pairs of the same tumors representing various cancer types,
and two FFPE-FF sample pairs of breast cancer cell lines, were included. Total RNA was
extracted and gene expression profiling was carried out using Illumina’s Whole-Genome
cDNA-mediated Annealing, Selection, extension and Ligation (WG-DASL) V3 arrays,
enabling the simultaneous detection of 24,526 mRNA transcripts. A sample exclusion crite-
rion was created based on the expression of 11 stably expressed reference genes. Pearson
correlation at the probe level was calculated for paired FFPE-FF, and three cut-off values
were chosen. Spearman correlation coefficients between the matched FFPE and FF
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samples were calculated for three probe lists with varying levels of significance and com-
pared to the correlation based on all measured probes. Unsupervised hierarchical cluster
analysis was performed to verify performance of the included probe lists to compare
matched FPPE-FF samples.
Results
Twenty-seven FFPE-FF pairs passed the sample exclusion criterion. From the profiles of
27 FFPE and FF matched samples, the best correlating probes were identified for various
levels of significance (Pearson P<0.01, n = 1,432; P<0.05, n = 2,530; and P<0.10, n = 3,351
probes). Unsupervised hierarchical clustering of the 27 pairs using the resulting probes
yielded 25, 21, and 19 correctly clustered pairs, respectively, compared to 1 pair when all
probes were used.
Conclusion
The proposed method enables comparison of gene expression profiles of FFPE and/or FF
origin measured on the same platform.
Background
Whole-genome microarray gene expression profiling has become an important tool for the
discovery of prognostic and predictive genes for various human cancers [1,2]. Until recently,
the main and preferred source of gene expression profiles was FF. In order to study larger
series of tissue samples for linking expression profiles with clinical follow-up, tissue archives
consisting of FFPE materials became an important source. However, the retrieval of RNA
from FFPE samples is challenging [3]. RNA isolated from FFPE samples can be significantly
degraded [4] and it may not contain the poly A tail for substrate binding of oligo (dT) primers
to generate cDNA [5]. In addition, formalin fixation causes cross-linkage between nucleic
acids and proteins [6]. Formalin reacts with nucleotides, leading to the introduction of mono-
methylol groups (-CH2OH) into the bases. These alterations can interfere with enzyme activ-
ity during the process of reverse transcription, which is a critical step in microarray sample
processing [7].
In breast cancer, the use of gene expression profiles to improve outcomes in defined popula-
tions was explicitly not recommended by the Evaluation of Genomic Applications in the Prac-
tice and Prevention (EGAPP) Working Group, because the evidence for the validity of the
test used was considered to be inadequate [8]. In the meantime, Illumina has developed an
assay called Whole-Genome cDNA-mediated Annealing, Selection, extension and Ligation
(WG-DASL) specifically designed for profiling FFPE and other partially degraded RNA sam-
ples. The WG-DASL assay does not depend on poly (A)/oligo(dT) based priming in the cDNA
synthesis stage. Instead, it relies on random nonamer priming. Random priming in conjugation
with PCR amplification may allow for the increased detection of low abundance transcripts. In
addition, the WG-DASL assay requires only short target sequences (~50 nucleotides) and
therefore, degraded RNA, such as the RNA obtained from FFPE, is sufficient for this assay [9].
So far, there have been several studies addressing the applicability and suitability of the Illu-
mina WG-DASL assay for FFPE material [9–18]. Some of these studies were performed by Illu-
mina to demonstrate the assay reliability, reproducibility and the applicability for low RNA
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input [9,11]. Only a few publications focused on the direct comparison between FF and FFPE
samples. Sfakianos and co-workers reported on a set of 30 matched FF-FFPE samples profiled
on two different platforms (Affymetrix and Illumina’s WG-DASL) and concluded that only
combinations of probes have the robustness to predict survival and classify ovarian cancer sub-
types while individual probe estimates may not yield satisfactory correlations between the
expression of genes isolated from FFPE and FF samples [16]. Mittempergher et al. compared
21 matched FF and FFPE gene expression profiles of breast cancer patients and found that the
transcripts with higher G/C percentages of the FF and FFPE matched samples correlated best
[19]. In other studies only selected gene sets were applied for the comparison of RNA expres-
sion between the FF and FFPE samples [20].
In the present study we describe a method to analyze RNA microarray data obtained from
matched FFPE and FF samples of patients suffering from various types of cancers. Our method
is based on data generated with Illumina’s WG-DASL BeadChips, but the principle can be
applied to different gene expression platforms. Besides describing a method to define a mini-
mum gene expression cut-off level, we developed a ruler system to reliably compare gene
expression profile data obtained from FFPE and FF samples, and demonstrate its use and valid-
ity. The ruler is based on various cut-off values indicating the number of probes with a pre-
specified Pearson correlation significance to be considered in the analysis.
Results
Sample exclusion criterion
In total, 70 FFPE and FF samples (28 FFPE-FF pairs + 14 duplicate hybridizations) were avail-
able to establish a sample-quality threshold (Table 1 & Fig 1). To this end, the median fluores-
cence intensity of 11 reference genes was calculated (see “Materials and Methods” for the
selection procedure, Table 2). A histogram of median reference gene intensity levels of all sam-
ples did not show a normal distribution (skewness -0.663) (S1A Fig). By applying an arbitrary
fluorescence expression threshold of 2,208, seven FFPE samples (6 from duplicate hybridiza-
tions and 1 from single hybridization) with a median below this threshold were excluded,
resulting in a close to normal distribution (skewness -0.150) (S1B Fig). Due to the duplicate
hybridizations which did pass the exclusion criteria, only 1 sample pair were lost to the analysis
because there was no FFPE data available. The other 25 tumors and 2 cell lines had all FFPE
and FF data available for further analyses (Fig 1). In case there were duplicate hybridizations
available for a sample, the one with the highest median level for the reference genes was kept.
In total, 54 FFPE and FF samples (25 FFPE-FE tumor pairs and 2 FFPE-FF cell line pairs) were
used for further analyses.
Selection of probes
For each individual probe the expression levels measured in 27 FFPE samples were correlated
with the case-matched FF levels. Three Pearson R cut-off P-values (P<0.01, P<0.05 and
P<0.10) were used for the inclusion of probes from the total set of 24,526 probes. The signifi-
cance levels of P<0.01, P<0.05 and P<0.10 allowed the inclusion of 1,697, 3,016 and 3,982
probes for analysis, respectively.
Next, the slope and y-axis intercept were calculated for each probe included at the individual
3 cut-offs. The mean of all slopes and the mean of all y-axis intercepts were calculated. All out-
lier probes (probes with slopes and/or y-intercept values outside of the mean ± one standard
deviation) were deleted. This yielded 1,432 out of 1,697 probes at P<0.01; 2,530 out of 3,016
probes at P<0.05; and 3,351 out of 3,982 probes at P<0.10. These 3 lists consisted of probes
with minimal variation in expression levels between FFPE and FF materials.
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Confirmation: comparing FFPE-FF sample pairs
Using the 3 probe lists, the Spearman rank correlation (Rs) was calculated between the expres-
sion of the probes of 27 sample pairs. The Rs ranged from Rs 0.74 to 0.99 using the 1,432
probes of the P<0.01 list; from 0.66 to 0.99 using 2,530 probes of the P<0.05 list; and from
0.63 to 0.99 using 3,351 probes of the P<0.10 list. The Rs between the expression of all probes
(24,526) for the 27 FF and FFPE samples ranged from 0.55 to 0.93 (Table 3).
Next, the 27 pairs were used for a clustering analysis. Unsupervised hierarchical clustering
using 1,432 probes (P<0.01) showed that 25 out of the 27 pairs clustered correctly together
(Table 3 bottom row and Fig 2A). The number of matched pairs decreased when using the
additional probes from different cut-off values: 22/27 pairs using 2,530 probes (P<0.05) (Fig
2B), and 19/27 pairs using 3,351 probes (P<0.10) (Fig 2C). In contrast, unsupervised clustering
of the 24,652 probes revealed a dominant effect of tissue handling: almost all FF samples clus-
tered separately from the FFPE samples while only one paired FFPE-FF sample clustered
together (Fig 2D).
Tissue specificity
To investigate a possible influence caused by the origin of the tissues on the gene expression
correlation between FFPE and FF samples, an identical analysis was performed restricted to the
FFPE-FF sample pairs of a single tumor type, namely 10 primary breast cancers and two breast
cancer cell lines. The same probe selection procedure as described above was followed, result-
ing in 1,118 reliable probes at P<0.01, 2,285 probes at P<0.05, and 3,937 probes at P<0.10.
The Spearman rank correlation coefficients and the clustering improved slightly for some
cases, but overall the results matched those of the entire set of 27 sample pairs (S2 Table).
Effect of normalization
The effect of data-normalization on the correlation was investigated by normalizing the data
obtained with the 12 FFPE and the 12 FF breast cancer samples separately in Lumi R, prior to
the correlation analyses, instead of normalizing all 24 samples combined. The correlation
between the expression patterns of the FFPE and FF samples was calculated starting from the
probe selection procedure. The individual normalization resulted in a slightly higher number
Table 1. List of FFPE-FF sample pairs included in the analysis.
Number of pairs Tumor types Number of hybridizations of FFPE Number of hybridizations of FF
10 breast cancer 3 samples 2x 7 samples 1x 3 samples 2x 7 samples 1x
4 brain metastases of lung cancer 2 samples 2x 2 samples 1x 2 samples 2x 2 samples 1x
3 brain metastases of kidney cancer 1x 1x
2 brain metastases of colon cancer 1x 1x
1 brain metastases of prostate cancer 1x 1x
1 brain metastasis of esophageal cancer 1x 1x
1 brain metastasis of leiomyosarcoma 1x 1x
1 brain metastasis of ovarian cancer 1x 1x
1 brain metastasis of endometrium 1x 1x
1 Brain metastasis of melanoma 1x 1x
1 brain metastasis of ACUP 1x 1x
2 breast cancer cell lines 2 x 2 x
FFPE = formalin-ﬁxed, parafﬁn-embedded; FF = fresh frozen; ACUP = adenocarcinoma of unknown primary.
doi:10.1371/journal.pone.0144097.t001
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of reliable probes at the different cut-offs, but did not influence the outcome of the Spearman
rank correlation analysis between the FFPE and FF sample pairs (S3 Table).
Reproducibility of the method in FFPE samples only
To study the reproducibility of the analysis of the FFPE samples only, 15 FFPE samples of vari-
ous tumor types and 2 breast cancer cell lines were measured twice (total of 34 hybridizations,
S1 Table). Following the exclusion criterion based on the minimummedian expression of
11 reference genes, 14 duplicate samples (28 hybridizations) were included in the analysis
Fig 1. Flow chart of the method followed to analyze FFPE-FF sample pairs. 70 FFPE and FF measurements (28 FFPE-FF pairs + 14 duplicate
hybridizations) were used to establish a sample-quality threshold. A threshold of 2,208 was chosen and 7 FFPE samples (6x of the duplicates and 1x of the
single hybridizations) with a median below this threshold were considered of poor quality and were excluded. Because the analysis is based on FFPE-FF
pairs, 7 FF pairs matching the 7 FFPE samples with low median of the reference genes were excluded from the analysis. In addition, to exclude bias in the
unsupervised analysis to be performed later, the two samples that remained from the duplicate hybridizations were excluded from the analysis. The duplicate
samples were selected based on their median reference gene values; duplicate samples with the lowest median reference gene values were excluded from
the analysis. Due to the duplicate hybridizations which did pass the exclusion criteria, only 1 sample pair was lost to the analysis because there was no FFPE
data available. The other 25 tumors and 2 cell lines had all FFPE and FF data available for further analyses In total, 54 FFPE-FF measurements (27 FFPE-FF
sample pairs) were used to develop the ruler based on the reliably measured probes.
doi:10.1371/journal.pone.0144097.g001
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(S2 Fig). Data were analyzed following the same method as described above. The Spearman
rank correlation coefficients ranged from 0.55 to 0.99 when all 24,526 probes were taken into
account. The Rs ranged from 0.88 to 0.99 at P<0.01 (2,732 probes), 0.84 to 0.99 at P<0.05
(4,700 probes), and 0.83 to 0.99 at P<0.10 (5,833 probes) (S4 Table). Hierarchical clustering
showed that all FFPE samples clustered with their duplicate when using the 3 cut-off values,
but also when using all 24,526 probes (S4 Table, bottom row).
Table 2. Stable reference gene selection based on 28 FF-FFPE pairs (56 samples).
Gene name Illumina code Average probe intensity GeNorm NormFinder Intragroup Intergroup
M-Value SD Accumulated SD FF FFPE FF FFPE
ACTB* ILMN_1343291 7733 0.35 0.32 0.20 0.10 0.12 -0.08 0.08
ATP5B ILMN_2038778 9027 0.41 0.53 0.13 0.09 0.26 -0.32 0.32
B2M ILMN_2094718 3452 0.53 0.52 0.13 0.27 0.29 -0.06 0.06
EEF1A1* ILMN_203877 19568 0.23 0.37 0.15 0.10 0.19 0.00 0.00
GAPDH ILMN_1713369 9813 0.47 0.41 0.14 0.05 0.26 0.15 -0.15
HMBS ILMN_1693311 5024 0.50 0.42 0.13 0.08 0.29 0.00 0.00
HPRT1 ILMN_2331501 3189 0.60 0.59 0.13 0.11 0.44 0.28 -0.28
RPL13A ILMN_2191428 1766 0.57 0.57 0.13 0.16 0.37 0.25 -0.25
TPT1 ILMN_1772132 21641 0.23 0.25 0.25 0.05 0.09 -0.06 0.06
UBB ILMN_1726306 6839 0.44 0.35 0.16 0.08 0.19 -0.04 0.04
UBC ILMN_2148459 10474 0.29 0.33 0.17 0.05 0.15 -0.14 0.14
median 11 selected reference
genes
7517 0.29 0.17 0.17 -0.05 0.05 0.04 0.03
ACTN1* ILMN_2216852 22697 0.84 1.10 0.14 0.54 0.63 -0.76 0.76
AKR1D1* ILMN_1722634 16970 0.80 0.88 0.13 0.09 0.57 -0.65 0.65
ALAS1 ILMN_1681374 3647 0.69 0.64 0.13 0.23 0.58 0.13 -0.13
ALDOA* ILMN_1801928 5516 0.98 1.54 0.16 1.80 2.24 0.61 -0.61
G6PD ILMN_2051232 6690 0.92 1.39 0.15 1.02 0.46 -1.04 1.04
GUSB ILMN_1669878 3186 0.73 0.79 0.13 0.08 0.84 0.41 -0.41
HSP90AB1 ILMN_2385647 9113 0.67 0.73 0.13 0.10 0.79 0.31 -0.31
NUCB1* ILMN_1673711 23216 0.78 0.83 0.13 0.08 0.59 -0.58 0.58
PGK1 ILMN_2347949 2145 0.71 0.68 0.13 0.20 0.64 -0.23 0.23
PUM1 ILMN_2056975 5360 0.75 0.83 0.13 0.09 0.56 0.58 -0.58
SDHA ILMN_1783424 3830 0.87 1.15 0.14 0.19 1.68 0.61 -0.61
TMBIM6 ILMN_2157277 11760 0.65 0.64 0.13 0.16 0.59 0.22 -0.22
YWHAZ ILMN_2232177 9990 0.62 0.62 0.13 0.06 0.38 0.40 -0.40
All samples from Table 1 were used. In case of duplicate hybridizations, the sample with the highest median value for the reference genes was selected.
GeNorm and NormFinder software were used to calculate the stability of genes. M-value; the average expression stability value, for which an arbitrarily
cut-off at 0.6 was used to assign genes as stably expressed or not. ACTB = Actin-Beta; ATP5B = ATP Synthase Subunit Beta; B2M = beta-2-microglobin;
EEF1A1 = eukaryotic translation elongation factor 1 alpha 1; GAPDH = Glyceraldehyde-3-Phosphate Dehydrogenase; HMBS = hydroxymethylbilane
synthase; HPRT1 = hypoxanthine phosphoribosyltransferase 1; RPL13A = ribosomal protein L13a; TPT1 = tumor protein, translationally-controlled 1; UBB
= ubiquitin B; UBC = ubiquitin C; ACTN1 = actinin, alpha 1; AKR1D1 = aldo-keto reductase family 1, member D1; ALAS1 = aminolevulinate, delta-,
synthase 1; ALDOA = aldolase A, fructose-bisphosphate; G6PD = glucose-6-phosphate dehydrogenase; GUSB = glucuronidase, beta; HSP90AB1 = heat
shock protein 90kDa alpha (cytosolic), class B member 1; NUCB1 = nucleobindin 1; PGK1 = phosphoglycerate kinase 1; PUM1 = pumilio RNA-binding
family member 1; SDHA = succinate dehydrogenase complex, subunit A, ﬂavoprotein (Fp); TMBIM6 = transmembrane BAX inhibitor motif containing 6;
YWHAZ = tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta.
* Belong to the housekeeping gene set of Illumina.
doi:10.1371/journal.pone.0144097.t002
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Discussion
Because most of the available data on RNA expression profiling in the literature has been gen-
erated from fresh frozen samples, it is important to establish methods for reliably comparing
gene expression profiles derived from FFPE and FF samples. In this study we investigated the
effects of tissue handling prior to processing for the RNA expression array technology and cal-
culated the correlation coefficients between the gene expression profiles at various levels of
stringency. Gene expression profiles obtained from matched FFPE and FF tumor and normal
adjacent lung tissue samples showed that the number of reliably measured probes was slightly
higher in FF samples as compared to FFPE samples [9]. The number of reliably measured
probes (P<0.01 calculated by GenomeStudio for the approximately 30 beads tagged with these
Table 3. Correlation between FFPE-FF sample pairs.
Number of Probes
Sample pairs 1,432 P<0.01 2,530 P<0.05 3,351P<0.10 24,526 P N.A
1 Breast Ca. 1 0.78 0.70 0.66 0.57
2 Breast Ca. 2 0.88 0.84 0.83 0.81
3 Breast Ca. 3 0.94 0.93 0.92 0.90
4 Breast Ca. 4 0.87 0.83 0.81 0.76
5 Breast Ca. 5 0.92 0.88 0.87 0.82
6 Breast Ca. 6 0.86 0.82 0.81 0.76
7 Breast Ca. 7 0.90 0.86 0.85 0.81
8 Breast Ca. 8 0.81 0.80 0.80 0.90
9 Breast Ca. 9 0.99 0.99 0.99 0.99
10 Breast Ca. 10 0.84 0.80 0.78 0.79
11 Brain meta. lung Ca. 1 0.86 0.83 0.81 0.76
12 Brain meta. Lung Ca. 2 0.85 0.80 0.78 0.75
13 Brain meta. Lung Ca. 3 0.76 0.72 0.72 0.74
14 Brain meta. Lung Ca. 4 0.86 0.84 0.83 0.81
15 Brain meta. colon Ca. 1 0.90 0.87 0.86 0.82
16 Brain meta. colon Ca. 2 0.79 0.73 0.70 0.55
17 Brain meta. kidney Ca. 1 0.88 0.84 0.83 0.74
18 Brain meta. kidney Ca. 2 0.83 0.78 0.77 0.67
19 Brain meta. kidney Ca. 3 0.90 0.86 0.85 0.77
20 Brain meta. prostate Ca. 0.87 0.85 0.83 0.73
21 Brain meta. oesophagus Ca. 0.84 0.79 0.78 0.69
22 Brain meta. Leiomyosarcoma 0.74 0.66 0.63 0.55
23 Brain meta. ovarian Ca. 0.83 0.80 0.78 0.75
24 Brain meta. endometrium Ca. 0.87 0.83 0.81 0.76
25 Brain meta. ACUP 0.83 0.79 0.78 0.75
26 Breast cell-line [MDA-MB-231] 0.96 0.96 0.96 0.93
27 Breast cell-line [SKBR3] 0.95 0.94 0.94 0.90
Number of matched pairs following
unsupervised hierarchical clustering
25/27 21/27 19/27 1/27
Rows 1 through 27 represent the paired samples of which the FFPE and FF parts were separately run on the Illumina WG-DASL V3 platform. The right
four columns show the Spearman rank correlation coefﬁcients between the expression values of the FF and FFPE materials for the distinct P-values
(0.01; 0.05; 0.10 and N.A. = Not Applicable). The upper row shows the numbers of probes included for the distinct levels of signiﬁcance. The number of
matched pairs following unsupervised hierarchical clustering is shown in the bottom row.
doi:10.1371/journal.pone.0144097.t003
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Fig 2. Dendrograms of matched FF and FFPE pairs at the three cut-off values. (A) Clusters based on 1,432 probes (P<0.01): only 2 FFPE samples did
not cluster with their FF counter pairs. (B) Clusters based on 2,530 probes (P<0.05): 6 FFPE samples did not cluster with their FF counter pairs. (C) Clusters
based on 3,351 probes (P<0.1): 8 FFPE samples did not cluster with their FF counter pair sample. (D) Clusters based on all the 24,526 profiled probes: the
main two arms of the dendrogram are based on the FFPE or FF samples. Each square represents a sample; Blue: FFPE; Green: FF, Red asterix indicates
the FFPE samples that did not cluster with their FF counterpart.
doi:10.1371/journal.pone.0144097.g002
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probes) in our study was also higher in the FF samples compared with the FFPE samples for
24/27 pairs. Only three FFPE samples had a higher number of reliably measured probes com-
pared with the FF samples.
The median expression of 11 reference genes was used to estimate the quality and quantity
of the input RNA. We defined a threshold for including samples based on the normal distribu-
tion of the median expression levels of these 11 reference genes. In earlier attempts of Thomas
et al., to match FF and FFPE gene expression data, the use of “percentage of genes present” was
recommended [2]. In that study however, only a single reference gene (DDX5) was used to
judge the quality of the expression profiles and a threshold based on the expression levels of
this gene for discarding samples of poor quality was recommended [2]. Some studies did not
specify a method to check the quality of the expression profiles [19–21], or only probes with P-
values of less than 0.05 were included [22]. Another study, which used Affymetrix gene expres-
sion profiles of FFPE samples, showed that almost half of the profiled samples (19/34) failed to
meet the stringent quality control criteria described by Affymetrix [23]. In our view, using the
median expression of multiple reference genes that are stably expressed in both FF and FFPE
samples, rather than only one gene, provides a better basis for judging the quality of profiled
gene expression arrays, especially for mixed FFPE and FF samples.
The present analysis was performed at the level of the probes, not genes, as some probes may
be better equipped to quantify the levels of a certain gene over different cohorts than others.
Using the average value of all probes that hybridize to a specific gene transcript may thus affect
the validity of the measurement. Our results indicate that simply including all measured probes
when analyzing data obtained from RNA expression profiling of FFPE and FF samples may lead
to false discoveries, which will be impossible to validate. The unsupervised hierarchical cluster-
ing using all measured probes showed a matching of samples that was almost solely based on
methods of tissue preparation (FFPE or FF) rather than on biological similarities (Fig 2D). Obvi-
ously, sensible comparisons of expression data from various sources, including FFPE and FF
procedures, can only be made if appropriate probes which correlate well between specimens
from different origin are considered. Increased stringency of inclusion of probes correlating well
between matched FFPE and FF specimens will inevitably lead to a significant reduction of
probes to be interpreted. We eliminated outlier probes based on the slope and the y- axis inter-
cept of the Pearson correlation plot between FFPE and FF paired samples, after which at the
level of P<0.01 only 1,432 (5.8%) of all probes passed the threshold of reliability. This number
increased to more than 10.3% (2,530 probes) when the P-value was raised to 0.05 and increased
to 13.7% (3,351 probes) when the P-value was further raised to 0.10. At P<0.01 the correlation
between the pairs ranged between 0.74–0.99 and the cluster analysis showed a match of 25 out
of the 27 pairs. The 2 non-matching samples in this analysis clustered to another breast cancer
sample, which may be explained by the heterogeneity within the tissue [10,19,24]. The number
of paired samples clustering together decreased after increasing the number of probes included
in the analysis. Clearly, the loss of information due to reduction of number of probes to be taken
into account is compensated by the gain in reliability of comparing FFPE with FF samples. This
way, stringent cut-off values (for example P<0.01) can reduce the number of validation experi-
ments. On the other hand, the more stringent P-values leading to relative low numbers of probes
to be taken into account will lead to a reduction in sensitivity of discovery. Therefore, we recom-
mend that the choice of the cut-off P-value for selecting reliably measured probes depends on
the resources and the number of samples used for both data analysis and validation studies. If
the validation group is relatively large, a researcher may choose to use p< 0.1. However, we rec-
ommend using the more stringent cut-off (P<0.01) if the validation experiments and the sample
size are limited. Probes that were not included in the gene lists are too different between an FF
or FFPE measurement of the same sample. Such genes are vulnerable to either the FF or FFPE
AMethod to Correlate mRNA Expression Data from FF-FFPE Tissue Samples
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pretreatments, and other methods than microarray analysis to obtain expression level data of
such genes are also at risk of measuring different levels in the FF or FFPE sample.
Several methods of analyzing IlluminaWG-DASL gene expression profiles of matched FFPE
and FF samples have been proposed previously. Direct comparisons between the expression
data from FFPE and FF samples of neoplastic and normal lung samples yielded correlations
around 0.7 [9]. Our approach yields a considerable improvement of correlation between FFPE
and FF material, with an average of 0.86 for the Pearson correlation when using the most strict
cut-off value (P<0.01) (Table 3) and the average correlation coefficients are still 0.83 and 0.81 at
the cut-off values of P<0.05 and P<0.10, respectively, as compared to 0.77 when all probes are
included. The improvement of the correlation is not influenced by the quality of the probes
because the results of repetitive measuring of probes of insufficient quality are inconsistent and
would negatively influence the correlation coefficients. In another study in which the expression
results of FFPE and matched FF samples of 20 breast cancers were compared, probes with high
expression variance were included. This method resulted in using 5,444 (20%) of the total
amount of probes [19]. This approach is comparable to our method, allowing the inclusion of
3,351 probes (13.7%) at P<0.10. However, only 19/27 pairs clustered together when applying
the unsupervised hierarchical clustering. Therefore, despite the increase of probes to be taken
into account, more extensive validation studies are necessary to confirm the findings.
The effects of the age of the paraffin blocks on RNA quality has been addressed previously
and in general, RNA degradation is more extensive in older paraffin blocks [25,26]. In our
series some samples were over 20 years old. In addition, samples were collected from various
centers in The Netherlands and therefore, fixation was not carried out in a uniform fashion. By
using the quality control as described, the effects of age and quality can be effectively compen-
sated for. Separate normalization of FFPE samples and FF samples was recommended previ-
ously for profiling samples on the Affymetrix platform [27]. It was shown that normalizing the
gene expression profiles of FFPE and FF samples together can skew the normalized data. Fol-
lowing the data analysis described in this study, separate normalization of the FFPE and FF
samples will not measurably affect or skew the data. Repeating our analysis after separate nor-
malization of the FFPE and FF samples, correlation coefficients slightly improved (S3 Table),
but the number of matched pairs identified by unsupervised hierarchical clustering was not
affected by the separate normalization.
The accuracy and sensitivity of profiling FFPE samples by repetitive measuring of samples
using various platforms like Illumina or Affymetrix has been scrutinized before
[2,9,13,19,20,22,28,29]. In this study we profiled 17 FFPE samples in duplicate. The samples
were subjected to the exclusion criterion and the expression data were correlated, yielding aver-
age Spearman rank correlations of 0.96 ± 0.03 when using the probes at P-value<0.01 as
compared to 0.90 ± 0.11 when including all probes (S4 Table). Similar improvements were
obtained when we used the FF samples for the duplicate studies (data not shown). All values
obtained from duplicate measurements resulted in matched clustering using the three cut-off
values. These results again highlight the accuracy and sensitivity of the current method to ana-
lyze Illumina WG-DASL platform data. Our analyses indicate that selecting the most corre-
lated probes to analyze profiled data obtained from FFPE samples only is a reliable method.
However, this selection of the most correlated probes may not be crucial to obtain good data
analysis results that can be validated.
Conclusion
In summary, we describe a novel and simple method to reliably compare gene expression data
derived from FFPE and FF samples, using probes with various levels of correlation strength (P-
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value<0.01,<0.05 and<0.10). The reliable probes identified by this method will vary between
different datasets. The method is applicable to various platforms, and is successful in selecting
probes yielding consistent signals across tumor types, and proved independent of the normali-
zation pre-processing. The number of probes to include and the comparison between FFPE
and FF samples is dependent on individual criteria for significance. Applying this method will
enable researchers to profile the archived FFPE samples and compare the data to already avail-
able profiled data obtained from FF samples. Our data however also show that, in order to ana-
lyze expression data from FFPE and FF samples, a trade-off (Fig 3) between the number of
included probes and the ability to accurately compare FFPE and FF samples will apply.
Materials and Methods
Tissue sample selection
Paired FFPE and FF tissue specimens of 26 tumors of various kinds and two cultured breast
cancer cell lines (MDA-MB-231 and SKBR3) were selected. Of 5 patients and 2 cell lines
enough RNA material was available from both FFPE and FE samples to perform duplicate
hybridizations using Illumina WG-DASL (Illumina, Scoresby, VIC, Australia). In total, 70
measurements were carried out [262 (FFPE-FF tumor sample pairs) + 22 (FFPE-FF cell line
pairs) + 72 (duplicate hybridizations: 3 FFPE-FF breast cancer pairs, 2 FFPE-FF brain metas-
tases of lung pairs, and 2 FFPE-FF cell line pairs)] (Table 1). In addition, to study the reproduc-
ibility of the established analysis workflow, following independent hybridizations RNA of 15
FFPE samples and 2 FFPE breast cancer cell lines (MDA-MB-231 and SKBR3) was profiled
twice (S1 Table). This study was approved by the Medical Ethics Committee of the Erasmus
Medical Center, Rotterdam, The Netherlands (MEC 02953) and performed in adherence to
the Code of Conduct of the Federation of Medical Scientific Societies in the Netherlands
(http://www.fmwv.nl/). Permission to use the biomaterials for this investigation was obtained
in writing. The institutional review board or ethics committee waived the need for consent
(according to the bylaw "code goes gebruik biologisch restmateriaal).
Morphological assessment
Five μmH&E sections from each sample were prepared before and after sectioning for RNA
isolation. To ascertain similar morphology of the sections used for the FFPE and matched FF
RNA isolation, the origins of the primary tumor, the percentages of the invasive tumor cells,
inflammatory infiltrates and the presence of necrosis were taken into consideration (JMK).
Only RNA isolated from sections with similar morphology was included for the matched
FFPE-FF comparisons.
RNA extraction and purification
Total RNA from FF tissue samples was, depending on the size of the sample, extracted from
20–30 sections of 30 μm using RNABee reagent according the supplier's instructions (Campro
Scientific, Veenendaal, The Netherlands). Depending on the size of the FFPE samples, RNA
was extracted from 3 to 6 x 20 μm sections. Following paraffin removal with xylene the high-
pure RNA paraffin kit was used according the supplier's instructions (Roche, Mannheim, Ger-
many). Following isolation, RNA was stored in RNase/DNase-free water at -80°C.
RNA quality control
The quantity and quality of the isolated RNA was monitored by UV spectroscopy and by
examination of rRNA bands after agarose gel electrophoresis. Samples were excluded if the
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yield did not reach the minimum requirement of 500 ng available for the FF samples and
1,000 ng for the FFPE samples. As an inner-assay control, 500 ng of FF RNA isolated from a
pool of several cultured breast cancer cell lines was used. The inner-assay control was used to
monitor the assay performance and to evaluate the inter-assay BeadChip variability for each
experiment.
Gene expression profiles
Illumina WG-DASL assay is an array-based method for expression profiling of partially
degraded RNA molecules such as those isolated from FFPE samples. In the assay 24,526 anno-
tated transcripts corresponding to 18,391 unique genes are measured. The WG-DASL assay
was performed according to the manufacturer’s instructions. In brief, 500 ng total RNA was
used from FF samples and 1,000 ng of total RNA from FFPE samples. 500 ng of total RNA
from the inner-assay control was included in each measurement. Total RNA was converted to
cDNA using biotinylated oligo-dT18 and random nonamer primers. The biotinylated cDNA
was annealed to the DASL Assay Pool (DAP) probe groups, which contain oligonucleotides
specifically designed to interrogate each target sequence of the transcript. The DAP was
annealed to targeted cDNA during a 16 hours temperature gradient (70° to 37°C) incubation.
Hybridization of these oligonucleotides to the targeted cDNA site, followed by enzymatic
extension and ligation was used to create a PCR template that was amplified with a set of
Fig 3. Ruler of the three cut-off values used to compare the gene expression profiles of FFPE and FF samples. Each Pearson P-value results in
different numbers of probes to be included for further analysis.
doi:10.1371/journal.pone.0144097.g003
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universal PCR primers [30]. Cy3-coupled primers were used to facilitate the precipitation of
the single stranded labeled products, which were hybridized to the whole genome Human
Ref8_V3_BeadChips containing 8 identical microarrays each. The microarrays were scanned
using a confocal type imaging system with Cy3 (532 nm) laser illumination (Illumina I-scan
reader N0262). Fluorescent intensities were read and images were extracted using software ver-
sion 1.8.13.5. Each sequence type is represented by an average of 30 beads on the array.
Data Analysis
Scanned data were uploaded into GenomeStudio software version 2011.1 via the Whole
Genome DASL gene expression module for further analysis. The average signal, detection P-
value, bead standard error and average beads were used to quantile normalize the data in the
statistical language R (www.r-project.org/) using the “Lumi” package [31].
In order to reach a reliable method to analyze profiled data from FFPE and FF samples, three
major analyses were performed: sample exclusion criteria, probe selection and confirmation.
Sample exclusion criterion
In addition to the 6 Housekeeping probe sets selected by Illumina, 18 reference genes were
selected based on the literature and tested for their signal intensity and stable expression level
between both FFPE and FF samples on this platform, using GeNorm [32] and NormFinder
[33] software packages. Eleven out of the 24 genes showed a stable expression in both FFPE
and FF samples with a minimum average expression stability value of 0.6 (Table 2). The
median expression level of the 11 reference genes was calculated and used to establish a mini-
mum lower threshold. Samples that did not meet the threshold for these 11 reference genes
were excluded (see Results section).
Probe selection
Expression levels, normalized by the ‘Lumi’ package, were used to calculate the correlation
coefficient (Pearson R2 correlation) at the individual probe level for all paired FFPE and
FF samples (n = 54; 27 pairs) that were left after applying the sample exclusion criterion.
Various levels of significance were used (P<0.01 [R2>0.49]; P<0.05 [R2>0.38] and P<0.10
[R2>0.32], respectively). To calculate the accuracy of the associations between the individual
probe values of FFPE and FF samples, the slope and the y-intercept were calculated for each
probe at the different cut-offs. The mean of all slopes and the mean of all y-intercepts were cal-
culated and all outlier probes (probes with expression values not within the mean ± standard
deviation) were disregarded.
Confirmation
Unsupervised clustering was performed using Cluster 3.0 using the correlation (uncentered)
average linkage method and Java Treeview 1.1.6 R2 was used for visualization [34].
Supporting Information
S1 Fig. Histogram of the log-transformed median expression of 11 reference genes prior
to- and following- the omission of samples with relatively low expression levels. (A) Imple-
menting all 70 samples resulted in a distribution with a skewness of -0.663. (B) Following the
deletion of 7 samples with a median< 2,208 (natural log-transformed (LN = 7.7)) fluorescent
expression level for the 11 reference genes the skew was reduced to an acceptable level
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(skewness of -0.150). The red line represents a normal distribution of the values.
(TIF)
S2 Fig. Flow chart of the method followed for the duplicate expression measurements of
FFPE samples. 34 FFPE measurements (17 duplicate FFPE samples) were used to apply the sam-
ple exclusion criteria that was established earlier in the study based on a threshold of 2,208. Three
FFPE samples with a median reference gene signal below this threshold were of poor quality and
were excluded. Because the analysis is based on FFPE duplicate measurements, the duplicate mea-
sures of 3 FFPE samples of poor quality were excluded from the analysis. In total, 28 FFPE mea-
surements (14 duplicate FFPE samples) were used to identify the reliably measured probes.
(TIF)
S1 Table. List of FFPE samples profiled in duplicate. FFPE = formalin-fixed, paraffin-embed-
ded; ACUP = adenocarcinoma of unknown primary.
(DOCX)
S2 Table. Effect of tissue origin on the Spearman rank correlation between FF and FFPE
samples. Rows 1 through 12 represent breast cancer paired samples of which the FFPE and FF
parts were separately run on the Illumina WG-DASL V3 platform. The right four columns
show the Spearman rank correlation coefficient between the expression values of the FF and
FFPE materials for various P-values (0.01; 0.05; 0.10 and N.A. = Not Applicable). The upper
row shows the numbers of probes included for the distinct levels of significance. The number
of matched pairs following unsupervised hierarchical clustering is shown in the bottom row.
(DOCX)
S3 Table. Effect of normalization on the Spearman rank correlation between FF and FFPE
samples. Rows 1 through 12 represent breast cancer FFPE and FF sample pairs which were
separately run on the Illumina WG-DASL V3 platform. The normalization was performed sep-
arately for the FF and FFPE samples. The right four columns show the correlation coefficient
(Spearman correlation) between the expression values of FF and FFPE materials for various p-
values (0.01; 0.05; 0.10 and N.A. = Not Applicable). The upper row shows the numbers of
probes included for the distinct levels of significance. The number of matched pairs following
unsupervised hierarchical clustering is shown in the bottom row.
(DOCX)
S4 Table. Reproducibility among repeated measurements of FFPE samples. Rows 1 through 14
represent the FFPE samples that were profiled twice on the IlluminaWG-DASL V3 platform. The
right four columns show the correlation coefficient (Spearman correlation) between the expres-
sion data of the duplicates for various p-values (0.01; 0.05; 0.10 and N.A. = Not Applicable). The
upper row shows the numbers of probes included for the distinct levels of significance. The num-
ber of matched pairs following unsupervised hierarchical clustering is shown in the bottom row.
(DOCX)
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